Explain this page
Arphra AIPlain-English read on Calidi Biotherapeutics, Inc.’s valuation06-08today
- Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study5d
- Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study5d
- Calidi Biotherapeutics Announces Investor Webinar on June 9, 202613d
- Calidi Biotherapeutics Announces Investor Webinar on June 9, 202613d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $5.50 (+3156.36%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +11.12% | +4.78% | -11.99% | -40.32% | -87.58% | -85.56% | -95.06% | -99.99% | -99.99% | -99.99% | -99.99% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$0.17
Bid
$0.15
420 sh
Ask
$0.18
1,300 sh
Spread
$0.032
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Studyglobenewswire.com·Jun 16, 2026
- Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Studyglobenewswire.com·Jun 16, 2026
- Calidi Biotherapeutics Announces Investor Webinar on June 9, 2026globenewswire.com·Jun 08, 2026
- Calidi Biotherapeutics Announces Investor Webinar on June 9, 2026globenewswire.com·Jun 08, 2026
- Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Bostonglobenewswire.com·May 13, 2026
Peers
No peer list available for CLDI.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|